CAS 1360053-81-1

Spebrutinib besylate

CAS : 1360053-81-1

Spebrutinib besylate is a salt form of spebrutinib, which is a small molecule tyrosine kinase inhibitor. It has been shown to inhibit the proliferation of lymphocytes in vitro and in vivo. The mechanism by which spebrutinib besylate inhibits cell proliferation is not fully understood, but it may be due to inhibition of tyrosine kinases and their downstream signaling pathways. Spebrutinib besylate also has potential antineoplastic activity, as it targets family members that are involved in the development and progression of lymphoma.

Formule : C₂₈H₂₈FN₅O₆S

Degré de pureté : Min. 95%

Masse moléculaire : 581.6 g/mol

Ref: 3D-KEC05381

Spebrutinib besylate

CAS : 1360053-81-1

Spebrutinib besylate (AVL-292 benzenesulfonate; CC-292 besylate) is a Btk kinase activity inhibitor (IC50<0.5 nM, Kinact/Ki=7.69×104 M-1s-1s).

Formule : C₂₈H₂₈FN₅O₆S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 581.62

Ref: TM-T14357